Where does Conaris Research Institute AG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Conaris Research Institute AG ranks #34,825 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Conaris Research Institute AG hold?

Conaris Research Institute AG holds 7 US utility patents granted between 2015 and 2023, spanning 3 technology areas.

What is Conaris Research Institute AG's Innovation Score?

Conaris Research Institute AG has an Innovation Score of 25.5 out of 100 (18th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Conaris Research Institute AG focus on?

Conaris Research Institute AG's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 7 patents, ranking #2,588 of 6,058 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

Is Conaris Research Institute AG's patent grant rate increasing or decreasing?

Conaris Research Institute AG's recent grant velocity is -25% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Conaris Research Institute AG's patents?

Conaris Research Institute AG's patents average 17.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Conaris Research Institute AG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Conaris Research Institute AG

USPTO PatentsView assignee record - 7 granted patents across 3 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Conaris ranks #34,825 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 3 technology areas.

#34,825
of 49,997 US assignees by volume: 18th percentile
by Innovation Score (25.5/100): 17.6
avg claims per patent: -25%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R34825 · Foreign Corporation #34,825 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 7 grants
MID-PACK #34,825/49,997
PHOTO-FINISH Colorobbia Italia S…
CPC-NARROW A61P · 3 areas
INNOV-THIN 25.5/100
CLAIMS-RICH 17.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -25% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Colorobbia Italia S.P.A. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Conaris’s 25.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (28%) Velocity 1.7 pts (7%) Breadth 6.1 pts (24%) Claim depth 10.5 pts (41%)

Qualcomm Incorporated · highest

85
Conaris Research… · this assignee

26
3D Lighting… · lowest

7

What this shows Conaris's Innovation Score is 25.5/100 (18th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Conaris?

Each dot is one of Conaris’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Conaris’s own 17.6 claims/patent is ABOVE the 11.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Conaris vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Conaris's grants concentrate

Conaris Research Institute AG is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2019 (2 grants) versus a trough of 1 in 2015. By volume, Conaris sits between Colorobbia Italia S.P.A. and Conquer Electronics Co., Ltd..

Conaris's three-year grant acceleration

Conaris Research Institute AG shows 1 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Colorobbia Italia…

7
Columbarium BY De…

7
Comnav Technology

7
Compagnie Engrena…

7
Concentric Analge…

7
Concept Workshop…

7
Concio Holdings

7
Conquer

7
Conaris Research… ◀

7

What this shows Conaris holds 7 patents at rank #34,713, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Conaris

By rank, the assignees closest to #34,713 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Conaris's primary technology class.

Conaris's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

26 18th percentile higher than 18% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Conaris Research Institute AG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	14.3%
2017	1	14.3%
2019	2	28.6%
2020	1	14.3%
2021	1	14.3%
2023	1	14.3%

Which technologies does Conaris Research Institute AG patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 7

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 7

C07K - Peptides 2

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Conaris Research Institute AG's patent record in context - here's where to go next.

Conaris Research Institute AG's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #34,825 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Conaris Research Institute AG against Colorobbia Italia S.P.A., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 25.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.